↓ Skip to main content

Org 4333, a potent, irreversibly binding estrogen agonist

Overview of attention for article published in International Journal of Clinical Pharmacy, August 1983
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
10 Dimensions
Title
Org 4333, a potent, irreversibly binding estrogen agonist
Published in
International Journal of Clinical Pharmacy, August 1983
DOI 10.1007/bf01961478
Pubmed ID
Authors

A. J. van den Broek, J. Leemhuis, M. S. de Winter, F. J. Zeelen

Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 1989.
All research outputs
#8,535,472
of 25,374,917 outputs
Outputs from International Journal of Clinical Pharmacy
#632
of 1,579 outputs
Outputs of similar age
#2,249
of 7,986 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#2
of 2 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,579 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 7,986 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.